45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Tony W Ho, MD

Dr
AstraZeneca
1800 Concord Pike
Wilmington, DE
USA 19803

Papers:
132 - Focused Plenary Analysis of intermediate clinical endpoints from a Phase II trial of olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC)